What Twist Bioscience Corporation told the SEC could break it.

Twist manufactures all of its products and multiple sub-assemblies at just two U.S. facilities (Wilsonville, Oregon and South San Francisco, California), but its core silicon-based DNA-synthesis output is concentrated at a single site: it has consolidated all synthetic-biology production in Wilsonville, and its high-throughput Express product line is manufactured solely in Wilsonville. If the Wilsonville facility were destroyed or experienced manufacturing difficulties, disruptions or delays, it would limit supply of the company's flagship synthetic-DNA products. A genuine single-facility, single-point-of-failure manufacturing concentration for the core product line.

“We have consolidated all synthetic biology production in Wilsonville, and our Express product line is manufactured solely in Wilsonville.”

Twist flags exposure to trade and national-security disputes, particularly with China — including sanctions, tariffs and other trade restrictions (both U.S. tariffs on Chinese imports and Chinese tariffs on U.S. goods) — that may affect its supply chain or sales opportunities in the United States, China and Europe. As a synthetic-DNA provider (a national-security-sensitive biotechnology sector) with ~42% of revenue from outside the U.S. and China among its APAC markets, escalating U.S.–China trade/national-security policy is a dual-sided exposure: it can raise input costs/disrupt supply and restrict access to the China market. A thesis-relevant but currently non-quantified trade-policy exposure (low severity).

“trade and national security disputes, particularly with China, including the effect of sanctions, tariffs and other trade restrictions that may affect supply chain or sales opportunities in the United States, China and Europe”

For reasons of quality assurance, sole-source availability or cost-effectiveness, certain components and raw materials used to manufacture Twist's products are available only from one supplier. The company says it has developed contingency plans, established some long-term supply contracts and qualifies additional suppliers for key materials — partial mitigation — but the underlying single-source dependence for specific (unnamed) inputs remains a supply-continuity risk: a supplier failure or shortage could create production shortfalls. A real but hedged sole-source exposure (low severity given the stated mitigations and unnamed/non-quantified scope).

“For reasons of quality assurance, sole source availability or cost effectiveness, certain components and raw materials used in the manufacture of our products are available only from one supplier.”